Last reviewed · How we verify
NCT05026658
Prospective, Randomized, Controlled Agreement and Reproducibility Clinical Study
NA trial testing Visibly Digital Acuity Product in Digital Acuity Product in 358 participants. Completed in 4 October 2021.
4 October 2021
Quick facts
| Lead sponsor | Visibly |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 358 |
| Start date | 22 July 2021 |
| Primary completion | 4 October 2021 |
| Estimated completion | 4 October 2021 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Visibly Digital Acuity Product
Conditions studied
- Digital Acuity Product — all drugs for Digital Acuity Product →
Sponsor
Visibly
Who can join
Adults 22 to 40, any sex, with Digital Acuity Product. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Visual acuity is the relative ability of the eye to resolve detail that is usually expressed as the reciprocal of the minimum angular separation in minutes of two lines just resolvable as separate and that forms in the average human eye an angle of one minute. Visibly Inc. has developed a method for determining a patient's visual acuity electronically via a web-based software system that can be self-administered wherever convenient. This method provides an efficient alternative for people to have immediate access to visual acuity measurements.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05026658
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Visibly trials
Trials by the same sponsor.
- NCT06812572 — A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision Test · NA · completed
- NCT03502863 — Clinical Study to Evaluate Effectiveness of Digital Refraction · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05026658 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Visibly
- Last refreshed: 4 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05026658.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing